Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.US-based Akron Biotechnology has announced its merger with AppliChem, a German manufacturer of chemicals and biochemicals.
Subscribe to our email newsletter
AppliChem and Akron Biotech are merging forces for the manufacturing and distribution of both companies’ products. Effective March 2, 2009, Akron Biotech has taken over AppliChem’s operations in the Americas and is called AppliChem, LLC. Claudia Zylberberg, Akron Biotech’s CEO, will continue to operate as the president and CEO of AppliChem, LLC.
AppliChem, LLC is committed to offering its customers the same high quality products including animal serum, recombinant proteins, serum-free media and other cell-culture components in addition to AppliChem’s full list of 4,000 products such as amino acids and powder media, the two companies said.
Dr Zylberberg said: “The merger with AppliChem will allow us to expand our product offering dramatically, and will accelerate our company’s growth. It presents an opportunity for us to expand our presence in the market by adding their full line.”